ONYX PHARMACEUTICALS INC: current_assets
| Value | {"amount": 684827000, "concept": "us-gaap:AssetsCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2012-03-31) |
| Status | current |
| Entity | ONYX PHARMACEUTICALS INC |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T09:49:46.140887+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/bc41cf07-4f32-4993-9fea-c3788d7b2bc9
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001193125-12-212281 · Open the official SEC filing →Retrieved: 2026-08-19T09:49:46.140887+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001012140/current-assets/2012-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/bc41cf07-4f32-4993-9fea-c3788d7b2bc9
History
- no predecessors — first report